Last edition
News about "innovative therapeutics"
Biocytogen Signs Non-Exclusive VHH Antibody Licensing Deal with Qilu Pharmaceutical
Biocytogen grants Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule developed through its RenNano platform to support neuroscience drug research.
Innovative Therapeutics | 04/09/2026 | By News Bureau | 113
Nona Biosciences Taps Dr. Hongjiang Miao to Advance A3 Strategy and AI-Driven Drug Discovery
Dr. Hongjiang Miao will lead the Nona AI team to advance the company's A3 (Antibody engineering × AI × Automation) strategy and further transform Nona into an AI-driven drug discovery company.
Innovative Therapeutics | 04/12/2025 | By Dineshwori | 272
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy